• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 691

Bacillus coagulans SANK 70258 spore preparation

Intended Use: As an ingredient providing up to 2 x109 CFU/serving in baked goods and baking mixes; beverages and beverage bases; breakfast cereals; chewing gum; coffee and tea; condiments and relishes; confections and frostings; dairy product analogs; fruit juices; frozen dairy desserts and mixes; fruit and water ices; gelatins, puddings, and fillings; grain products and pastas; hard candy; herbs, seeds, spices, seasonings, blends, extracts, and flavorings; jams and jellies; milk; milk products; nuts and nut products; plant protein products; processed fruits; processed vegetables and vegetable juices; snack foods; soft candy; soups and soup mixes; sugar; and sweet sauces, toppings and syrups.
Basis: Scientific procedures
Notifier: Mitsubishi-Kagaku Foods Corporation
Notifier Address: 1-1 , Marunouch i
1-chome Chiyoda-ku,
Tokyo 100-8251
GRAS Notice (releasable information): GRN 691 (in PDF) (14.0 MB)
Date of closure: Aug 28, 2017
FDA's Letter: FDA has no questions (in PDF) (54 kB)